Feedback / Questions
mipasetamab uzoptirine (ADCT-601) - Overland ADCT BioPharma
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Zynlonta (loncastuximab tesirine) - Overland ADCT BioPharma
Keytruda (pembrolizumab) - Merck (MSD)
https://www.businesswire.com/news/home/20211102005333/en/ADC-Therapeutics-Reports-Third-Quarter-2021-Financial-Results-and-Provides-Business-Updates
Nov 2, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next